KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,853,226 | +90.3% | 10,960 | +144.0% | 0.01% | +66.7% |
| Q2 2023 | $973,873 | -69.9% | 4,491 | -72.7% | 0.00% | -76.9% |
| Q4 2022 | $3,235,373 | -37.1% | 16,465 | -28.0% | 0.01% | -50.0% |
| Q3 2022 | $5,145,000 | +1554.3% | 22,876 | +738.3% | 0.03% | +2500.0% |
| Q2 2021 | $311,000 | -79.6% | 2,729 | -81.8% | 0.00% | -90.9% |
| Q4 2020 | $1,522,000 | -13.2% | 14,982 | -34.0% | 0.01% | -54.2% |
| Q3 2020 | $1,754,000 | -73.1% | 22,684 | -61.2% | 0.02% | -77.1% |
| Q2 2020 | $6,520,000 | +1255.5% | 58,498 | +775.7% | 0.10% | +775.0% |
| Q1 2020 | $481,000 | – | 6,680 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |